journal article·2026-11

An antibody-conjugated polymer nanoparticle that targets inflammatory site for abdominal aortic aneurysm antioxidant stress therapy

Youjin Huang, Qi'’nan Yin, Qin Zhang, Jinping Liu, Ya Wu, Yong Liu

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Aortic aneurysm repair treatments · Infectious Aortic and Vascular Conditions · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. What is an abdominal aortic aneurysm?10.1001/jama.2022.18638 ↗
2. Abdominal aortic aneurysm
3. Diminished spinal cord perfusion despite distal aortic perfusion: an acute translational large animal experiment with occluded segmental arteries10.1093/ejcts/ezae460 ↗
4. Medical treatment of small abdominal aortic aneurysm
5. Some asymptomatic abdominal aortic aneurysms smaller than 5.5 cm can be considered for elective repair10.1016/j.jvs.2018.01.042 ↗
6. Abdominal aortic aneurysm: update on pathogenesis and medical treatments10.1038/s41569-018-0114-9 ↗
7. Immune and inflammatory mechanisms of abdominal aortic aneurysm10.3389/fimmu.2022.989933 ↗
8. The role of vascular smooth muscle cells in the development of aortic aneurysms and dissections10.1111/eci.13697 ↗
9. Cytokines in abdominal aortic aneurysm: master regulators with clinical application10.1177/11772719221095676 ↗
10. Interleukin-6 receptor pathways in abdominal aortic aneurysm10.1093/eurheartj/ehs354 ↗
11. Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture10.1016/j.ejvs.2008.11.017 ↗
12. Effect of losartan on cell proliferation and reactive oxygen species scavenging in gastric cancer cell lines10.14744/ejmo.2024.61923 ↗
13. Oxidative stress and abdominal aortic aneurysm: potential treatment targets10.1042/CS20150547 ↗
14. Genetic and epigenetic mechanisms underlying vascular smooth muscle cell phenotypic modulation in abdominal aortic aneurysm10.3390/ijms21176334 ↗
15. Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures10.1111/j.1582-4934.2010.01036.x ↗
16. A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation10.1371/journal.pone.0053882 ↗
17. Nanoencapsulation of gla-rich protein (GRP) as a novel approach to target inflammation
18. Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection10.1161/HYPERTENSIONAHA.110.152298 ↗
19. Nanoparticle-assisted diagnosis and treatment for abdominal aortic aneurysm
20. Recent advances in nanomedicine-mediated abdominal aortic aneurysm treatment
21. Role of 2-methoxyestradiol, an endogenous estrogen metabolite, in health and disease10.2174/1389557515666150226121052 ↗
22. Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: implications for cancer therapy10.1016/j.cytogfr.2025.01.003 ↗
23. 2-Methoxyestradiol ameliorates doxorubicin-induced cardiotoxicity by regulating the expression of GLUT4 and CPT-1B in female rats10.1007/s00210-024-03073-z ↗
24. IL-6: a Janus-like factor in abdominal aortic aneurysm disease10.1016/j.atherosclerosis.2016.06.021 ↗
25. Circulating interleukin-6 levels are associated with abdominal aortic aneurysm presence: a meta-analysis and meta-regression of case-control studies10.1016/j.avsg.2014.06.058 ↗
26. Protein drug targets for abdominal aortic aneurysm and proteomic associations between modifiable risk factors and abdominal aortic aneurysm10.1161/JAHA.124.037802 ↗
27. Redox metabolism: ROS as specific molecular regulators of cell signaling and function10.1016/j.molcel.2021.08.018 ↗
28. Mitochondria in health and disease10.3390/cells8070680 ↗
29. Mitochondrial quality control in abdominal aortic aneurysm: from molecular mechanisms to therapeutic strategies10.1096/fj.202202158RR ↗
30. Nuclear receptor NR1D1 regulates abdominal aortic aneurysm development by targeting the mitochondrial tricarboxylic acid cycle enzyme aconitase-210.1161/CIRCULATIONAHA.121.057623 ↗
31. Neutrophil extracellular trap-induced ferroptosis promotes abdominal aortic aneurysm formation via SLC25A11-mediated depletion of mitochondrial glutathione10.1016/j.freeradbiomed.2024.05.036 ↗
32. Enhancing exosomal delivery to abdominal aortic aneurysms using magnetically responsive chemotactic nanomotors for elastic matrix regenerative repair10.4028/b-wjQRP6 ↗
33. Extravascular administration of IGF1R antagonists protects against aortic aneurysm in rodent and porcine models10.1126/scitranslmed.adh1763 ↗
34. Decellularized adipose matrix hydrogel-based in situ delivery of antagomiR-150-5p for rat abdominal aortic aneurysm therapy
35. Peptide amphiphile supramolecular nanofibers designed to target abdominal aortic aneurysms10.1021/acsnano.1c06258 ↗
36. Effective hydrogel vascular patch dual-loaded with cycloastragenol nanostructured lipid carriers and doxycycline for repairing extravascular injury in abdominal aortic aneurysm